NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 44.94% | 97.59% | 91.72% | 97.62% | 51.99% |
| Total Depreciation and Amortization | 4.80% | 6.10% | 6.41% | 2.13% | -20.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 137.68% |
| Total Other Non-Cash Items | -24.60% | -91.54% | -95.96% | -101.28% | 857.05% |
| Change in Net Operating Assets | -57.49% | -107.92% | 517.06% | 154.99% | -37.52% |
| Cash from Operations | -6.25% | -4.08% | 236.33% | 317.76% | 163.98% |
| Capital Expenditure | -141.10% | -45.17% | 72.20% | 72.81% | 78.06% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -159.31% | 318.60% | 218.33% | 191.02% | 179.39% |
| Total Debt Issued | -97.50% | -100.00% | 676.67% | -- | 1,904.00% |
| Total Debt Repaid | 56.14% | 11.23% | -3.46% | -15.12% | -28.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35.86% | -38.61% | -5.18% | 0.00% | 0.00% |
| Cash from Financing | 46.13% | -28.95% | 21.26% | 17.06% | 3.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.02% | 199.59% | 151.04% | 136.30% | 128.60% |
